This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
申请公布号
AU2011217809(A1)
申请公布日期
2012.09.06
申请号
AU20110217809
申请日期
2011.02.22
申请人
GLAXOSMITHKLINE LLC
发明人
ADAMS, NICHOLAS D.;AQUINO, CHRISTOPHER JOSEPH;CHAUDHARI, AMITA M.;GHERGUROVICH, JONATHAN M.;KIESOW, TERENCE JOHN;PARRISH, CYNTHIA A.;REIF, ALEXANDER JOSEPH;WIGGALL, KENNETH
